This paper is in the following e-collection/theme issue:

Viewpoints on and Experiences with Digital Technologies in Health (79) Quality Improvement (253) Decision Support for Health Professionals (1185) Big Data (240)

Published on in Vol 10, No 6 (2022): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34204, first published .
Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus

Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus

Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus

Authors of this article:

Peter Klimek1, 2 Author Orcid Image ;   Dejan Baltic3 Author Orcid Image ;   Martin Brunner4 Author Orcid Image ;   Alexander Degelsegger-Marquez5 Author Orcid Image ;   Gerhard Garhöfer4 Author Orcid Image ;   Ghazaleh Gouya-Lechner3 Author Orcid Image ;   Arnold Herzog6 Author Orcid Image ;   Bernd Jilma4 Author Orcid Image ;   Stefan Kähler7 Author Orcid Image ;   Veronika Mikl3 Author Orcid Image ;   Bernhard Mraz3 Author Orcid Image ;   Herwig Ostermann5 Author Orcid Image ;   Claas Röhl8 Author Orcid Image ;   Robert Scharinger9 Author Orcid Image ;   Tanja Stamm4 Author Orcid Image ;   Michael Strassnig10 Author Orcid Image ;   Christa Wirthumer-Hoche6 Author Orcid Image ;   Johannes Pleiner-Duxneuner3 Author Orcid Image
Article Authors Cited by (6) Tweetations Metrics

Journals

  1. Yao Y, Yang F. Overcoming personal information protection challenges involving real-world data to support public health efforts in China. Frontiers in Public Health 2023;11 View
  2. Saucedo S, Silva K, Silva L, Crivelari J, Costa R. The impact of data quality monitoring of a multicenter prospective registry of cardiac implantable electronic devices. MethodsX 2023;11:102454 View
  3. Ali Z, Al-Mousawi A, Björnsson B, Egeberg A, Riemer C, Thomsen S. The Agreement between Consumer-Driven Self-Assessment of Psoriasis Severity and Physician-Assessed Severity Based on Patient-Taken Photographs Is Weak: A Cross-Sectional Study. Dermatology 2024;240(3):362 View
  4. Radaeva K, Mishinova S. Current issues related to the off-label use of drugs and their potential solutions. Real-World Data & Evidence 2024;4(1):24 View
  5. Lee H, Ahn H, Kwon S, Kang H, Han E. Expert survey on real‐world data utilization and real‐world evidence generation for regulatory decision‐making in drug lifecycle in Korea. Clinical and Translational Science 2024;17(4) View
  6. Mikl V, Baltic D, Czypionka T, Degelsegger-Márquez A, Forgó N, Gouya-Lechner G, Herzog A, Klimek P, Lumenta D, Mraz B, Ostermann H, Scharinger R, Stamm T, Strassnig M, Zeitlinger M, Pleiner-Duxneuner J. A national evaluation analysis and expert interview study of real-world data sources for research and healthcare decision-making. Scientific Reports 2024;14(1) View